Business models I: Service company

Wednesday June 26th, 09:30 - 10:30


(Bio)Pharmaceutical companies focus on the successful development of their potential new compounds. This is requires enormous amounts of (financial) resources and time. Too often however this focus on product developments creates a blind spot for the organizational development. Are all internal processes optimally geared to achieve the ultimate goal of the company? And what in fact is the ultimate goal? Based on a case presentation mixed with managerial models André van de Sande shows the importance of a strong focus of organizational development.

About Xendo

Xendo, a ProPharma Group company, is a leading consultancy and project management organisation in the fields of (bio)pharmaceutical products, medical devices, and healthcare. Thanks to our multi-disciplinary, knowledge-driven approach, we deliver a broad palette of services to the life sciences industry, applying the right colour to projects we participate in. For over 25 years, we have successfully completed thousands of national and international assignments for start-ups as well as for the largest, established multinational companies and organisations. ProPharma Group combined with Xendo has more than 1,000 professionals worldwide providing an unmatched variety of compliance related services including medical information, pharmacovigilance, clinical safety, regulatory affairs, and a continuously expanding range of compliance, quality assurance, validation, and consulting services; providing a full-colour spectrum.

André van de Sande

André van de Sande

CEO, Xendo
Senior Executive with over 25 years of Life Sciences experience in both mature and emerging markets in Western and Central Europe, Asia Pacific and Middle East Africa. Has successfully managed country and regional teams of up to 1100 employees and a turnover of €350 million. Extensive change management experience. Broad Non Executive and Advisory board experience with a.o. Lloyds Pharmacies and as chairman of BioFarmind. Leads now since more than five years Dutch Consultancy firm Xendo. Following a successful turnaround, Xendo was sold in 2016 to a British PE firm and is now being transformed into a global consultancy business. Holds a MBA degree from Tilburg university, The Netherlands and a MSc in Management from Purdue University, USA. Followed also the supervisory board member program of Nyenrode University. Fluent in Dutch, English and German. Reasonable knowledge of French and Hungarian.

Jumpstart your career

Join BioBusiness Summer School to jumpstart your career in Life Sciences by gaining knowledge of business aspects such as product development, IPR, finance and business models. The next edition of the summer school will be organised from 24-28 June 2019 in Amsterdam, the Netherlands.

Why participate

The BioBusiness Summer School is a programme tailored to bridge the gap. By immersing yourself in the business aspects of Life Sciences during this programme, you will learn the basic knowledge of BioBusiness, gain insight in the world of Life Sciences companies, meet leading business leaders and increase your international network.

Employers meet talent

Is your organisation interested in early-career talents in Life Sciences? BioBusiness Summer School can get you in touch with business oriented PhDs, postdocs or Master students. More info can be found here.